Related Experiment Video
Updated: Jun 5, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Effect of body mass index on breast cancer prognosis: a focus on ER/PR status and subtype-specific recurrence risk
Qinyan Shen1, Liangying Zhao1, Minjun Lu1
1Department of Surgical Oncology, Affiliated Dongyang Hospital of Wenzhou Medical University Dongyang 322100, Zhejiang, China.
Objective:
To explore prognostic differences in breast cancer (BC) recurrence risk across estrogen receptor (ER) and progesterone receptor (PR) defined subtypes, stratified by body mass index (BMI) categories, aiming to identify potential mechanisms.
Methods:
A cohort of 358 breast cancer patients provided data on height, weight, menopausal status, and receptor profiles for analysis.
Results:
Our findings highlighted that BMI's impact on BC prognosis was significantly influenced by ER/PR tumor status. In premenopausal women, BMI notably affected recurrence rates, especially in patients with ER-positive and PR-positive subtypes.
Conclusions:
Adjusting treatment strategies based on BMI across different menopausal statuses and tumor subtypes could improve outcome for patients with ER-positive/PR-positive tumors.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Mitogens and the Cell Cycle
Bulimia Nervosa

